Clinical Trial Update: Impact of Menstrual Cycle on Antiretroviral Pharmacokinetics in HIV-Infected Women

View source ↗

Summary

The study examining how the menstrual cycle influences antiretroviral pharmacokinetics in HIV-infected women has been withdrawn from clinicalTrials.gov.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: HIV Infected | Status: WITHDRAWN